Publications by authors named "A Tamagawa"
Background/aim: The aim of the present study was to evaluate the clinical impact of the Global Immune-Nutrition-Information Index (GINI) in patients with esophageal cancer (EC) who received curative treatment and to clarify the potential of the GINI as a prognostic factor.
Patients And Methods: Patients who underwent curative resection for EC at Yokohama City University between 2000 and 2020 were consecutively chosen based on their medical records. The GINI was defined as follows: GINI=[C-reactive protein×platelet×monocyte×neutrophil]/[albumin×lymphocyte].
Article Synopsis
- This study examined how anemia affects short- and long-term outcomes in patients with resectable gastric cancer undergoing curative treatment.
- A total of 330 patients were reviewed, revealing that those with preoperative hemoglobin levels below 11 g/dl had significantly lower survival rates compared to those with higher levels.
- The findings suggest that addressing perioperative anemia could improve the overall survival and reduce complications for gastric cancer patients receiving treatment.
Background/aim: We hypothesized that the inflammatory burden index (IBI) is a promising biomarker for esophageal cancer (EC) treatment and management. To confirm our hypothesis, we evaluated the prognostic impact of IBI in patients with EC who received curative treatment.
Patients And Methods: We conducted a retrospective review of medical records and collected data from consecutive patients with EC who underwent curative resection at Yokohama City University between 2005 and 2020.
Article Synopsis
- The study investigates the systemic immune-inflammation index (SII) as a predictor of prognosis in patients with esophageal cancer who had curative surgery.
- Researchers analyzed data from 180 patients, classifying them into SII-high and SII-low groups based on a cutoff value of 500, finding significant differences in overall survival (OS) and recurrence-free survival (RFS) rates between the two groups.
- Results showed that a higher SII correlated with poorer survival outcomes and a greater chance of hematological recurrence, indicating that the SII could be a valuable marker for managing esophageal cancer.
Background/aim: We hypothesized that the hemoglobin, albumin, lymphocyte, and platelet (HALP) score may be a promising marker for the treatment and management of gastric cancer (GC). To test this hypothesis, we evaluated the clinical impact of the HALP score in patients with GC who received curative treatment.
Patients And Methods: Consecutive patients who underwent curative resection for GC at the Yokohama City University between 2005 and 2020 were selected based on their medical records.